Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin

Oncogene, Published online: 22 June 2023; doi:10.1038/s41388-023-02750-2Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin

Source: Oncogene - June 22, 2023 Category: Cancer & Oncology Authors: Yihuan Chen Xiaoshuo Dai Wei Chen Yan Qiao Ruihua Bai Xiaoxuan Duan Kai Zhang Xinhuan Chen Xin Li Saijun Mo Wenbo Cao Xiang Li Kangdong Liu Ziming Dong Jing Lu Source Type: research